Farmak’s specialists have developed L’esfal hepatoprotective drug of broad use spectrum and introduced it to the market. A new product is released in form of solution for injections.
L’esfal contains essential phospholipids (1 ml solution contains phosphatidylcholine out of soybeans 50 mg), needed to recover the structure and functions of the liver cells.
Kateryna Myrgorodska, Farmak’s Product Manager of OTC Drugs Marketing Department: “L’esfal is prescribed for the treatment of acute and chronic hepatitis, cirrhosis, fat and alcoholic liver disease, toxicosis in pregnant women and dermatological diseases.
The drug not only protects the liver from different destructive effects but recovers its affected structure. It should be noted that L’esfal may be prescribed for the children aged 12 years and older and pregnant and breast-feeding women”.
In total, the Fund donated over UAH 4 million to fight the COVID-19 pandemic in the Ruzhynskyi district, as well as to reconstruct and equip a first-aid post in Nemyryntsi village As part of the anti-pandemic campaign, the Zhebrivski Family Charitable Foundation provided the Municipal Non-Commercial Enterprise “District Central Hospital” of the Ruzhynskyi Di...
The video presents a story of a typical day of several Farmak employees who get up before dawn, take care of their loved ones and go to work to fulfil an important mission. In such a simple form, the director portrayed Farmak as the Company with a soul, where employees are ordinary people, with their […]
Due to the new manufacturing facility, the Company will increase the manufacturing of sterile liquid medicinal products, the demand for which has significantly grown during the pandemic. The new manufacturing facility is a seven-storey building with over 20 units of main technological equipment and about 100 engineering equipment. It was built from the groun...